{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:02:40Z","timestamp":1791298960315,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202038"],"award-info":[{"award-number":["82202038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221085"],"award-info":[{"award-number":["BK20221085"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.xcrm.2023.101310","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T10:44:48Z","timestamp":1702982688000},"page":"101310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7"],"prefix":"10.1016","volume":"4","author":[{"given":"Xiangyu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-3428","authenticated-orcid":false,"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101310_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.molmed.2022.02.010","article-title":"Role of inflammasomes in HIV-1 infection and treatment","volume":"28","author":"Jin","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101310_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101310_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41556-020-0510-3","article-title":"Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity","volume":"22","author":"Huang","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101310_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib6","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni.3015","article-title":"RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib9","article-title":"Regulation of Inflammatory Cell Death by Phosphorylation","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib10","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2023.101310_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib13","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib16","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1073\/pnas.1201836109","article-title":"NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis","volume":"109","author":"Inoue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101310_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib18","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.3389\/fimmu.2019.02538","article-title":"Pharmacological Inhibitors of the NLRP3 Inflammasome","volume":"10","author":"Zahid","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib19","article-title":"Tivantinib alleviates inflammatory diseases by directly targeting NLRP3","volume":"26","author":"Huang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2023.101310_bib20","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101310_bib21","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101310_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2023.101310_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101310_bib24","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101310_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jim.2014.05.018","article-title":"Applying caspase-1 inhibitors for inflammasome assays in human whole blood","volume":"411","author":"Lipinska","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2023.101310_bib26","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1039\/D2FO01730J","article-title":"Sennoside A is a novel inhibitor targeting caspase-1","volume":"13","author":"Wu","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.xcrm.2023.101310_bib27","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/s41401-022-00913-7","article-title":"Novel Caspase-1 inhibitor CZL80 improves neurological function in mice after progressive ischemic stroke within a long therapeutic time-window","volume":"43","author":"Pan","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.xcrm.2023.101310_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat2738","article-title":"Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis","volume":"3","author":"Rathkey","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib29","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.abb9818","article-title":"Succination inactivates gasdermin D and blocks pyroptosis","volume":"369","author":"Humphries","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101310_bib30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2147\/TCRM.S147381","article-title":"Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors","volume":"14","author":"Liu","year":"2018","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.xcrm.2023.101310_bib32","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/1078-0432.CCR-20-2771","article-title":"FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors","volume":"27","author":"Marcus","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101310_bib33","article-title":"Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion-Positive NSCLC","volume":"3","author":"Drilon","year":"2022","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.xcrm.2023.101310_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112974","article-title":"Entrectinib, a new multi-target inhibitor for cancer therapy","volume":"150","author":"Jiang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2023.101310_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K(+) Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101310_bib36","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib37","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/eji.200838549","article-title":"The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity","volume":"38","author":"Franchi","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib39","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.1240248","article-title":"Noncanonical inflammasome activation by intracellular LPS independent of TLR4","volume":"341","author":"Kayagaki","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101310_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature07710","article-title":"AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA","volume":"458","author":"Fernandes-Alnemri","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib43","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chom.2010.11.007","article-title":"Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing","volume":"8","author":"Broz","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2023.101310_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101310_bib45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cell.2018.09.047","article-title":"The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen Infection","volume":"175","author":"Hara","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101310_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101310_bib47","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101310_bib48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib49","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41423-021-00683-y","article-title":"RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor","volume":"18","author":"Chen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib50","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2023.101310_bib51","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.immuni.2022.10.021","article-title":"IKKbeta primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network","volume":"55","author":"Schmacke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101310_bib52","doi-asserted-by":"crossref","first-page":"34897","DOI":"10.1074\/jbc.M303663200","article-title":"A mitotic cascade of NIMA family kinases. Nercc1\/Nek9 activates the Nek6 and Nek7 kinases","volume":"278","author":"Belham","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.101310_bib53","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1016\/j.febslet.2006.10.069","article-title":"Nek7 kinase is enriched at the centrosome, and is required for proper spindle assembly and mitotic progression","volume":"580","author":"Yissachar","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.xcrm.2023.101310_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.606996","article-title":"Physiological and Pathological Roles of Mammalian NEK7","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.xcrm.2023.101310_bib55","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.molcel.2017.01.015","article-title":"Nek7 Protects Telomeres from Oxidative DNA Damage by Phosphorylation and Stabilization of TRF1","volume":"65","author":"Tan","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2023.101310_bib56","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1128\/MCB.01867-08","article-title":"The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis","volume":"29","author":"O'Regan","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2023.101310_bib57","article-title":"NLRP3 Inflammasome and Inflammatory Diseases","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.xcrm.2023.101310_bib58","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2023.101310_bib60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5582\/bst.2020.01029","article-title":"NEK7: a potential therapy target for NLRP3-related diseases","volume":"14","author":"Liu","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.xcrm.2023.101310_bib61","article-title":"An RRx-001 Analogue With Potent Anti-NLRP3 Inflammasome Activity but Without High-Energy Nitro Functional Groups","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.xcrm.2023.101310_bib62","article-title":"Inhibition of the NLRP3 Inflammasome Activation by Manoalide Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis","volume":"10","author":"Li","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2023.101310_bib63","doi-asserted-by":"crossref","first-page":"34897","DOI":"10.1074\/jbc.M303663200","article-title":"A Mitotic Cascade of NIMA Family Kinases","volume":"278","author":"Belham","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.101310_bib64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/neuonc\/noaa052","article-title":"Entrectinib, a TRK\/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein","volume":"22","author":"Fischer","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2023.101310_bib65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-021-01503-3","article-title":"Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC","volume":"81","author":"Frampton","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.xcrm.2023.101310_bib66","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ni.3333","article-title":"NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component","volume":"17","author":"Shi","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101310_bib67","article-title":"Protocol for in\u00a0vivo and in\u00a0vitro activation of NLRP3 inflammasome in mice using monosodium urate","volume":"4","author":"Liu","year":"2023","journal-title":"STAR Protoc."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123005049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123005049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T23:00:32Z","timestamp":1762988432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123005049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":67,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2666379123005049"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101310","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101310"}}